Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Share Market News
Volpara delivers further explosive growth in FY 2019
Record Highs
Morgans slaps $23.69 share price target on Pro Medicus
Share Gainers
Why Fluence, Galaxy, Lendlease, & Volpara shares stormed higher today
Share Gainers
Why the Volpara share price is charging 6% higher today
Share Market News
Leading broker names 5 high conviction ASX shares to buy in May
Share Fallers
Why a2 Milk, Bank of Queensland, Super Retail, & Volpara shares tumbled lower today
Share Gainers
ALL ORDINARIES finishes lower Tuesday: 8 shares you missed
Share Fallers
Why LiveTiles, Redbubble, Resolute, & Volpara shares sank lower today
Growth Shares
Quarterly update: Is the Volpara share price in the buy zone?
52-Week Highs
Here's why the Volpara share price has nearly tripled over the last year
Speculative
3 exciting ASX small cap shares tipped for big things
Share Fallers
Why Blackmores, G8 Educations, Perseus Mining, & Volpara shares tumbled lower today
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.
